Latest News about ALNY
Recent news which mentions ALNY
Here's How Much $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today
February 28, 2024
From Benzinga
Why Is Alnylam Pharmaceuticals Stock Trading Lower On Thursday?
February 15, 2024
From Benzinga
Why Alnylam Pharmaceuticals Stock Is Sinking Today
February 15, 2024
From Motley Fool
Earnings Scheduled For February 15, 2024
February 15, 2024
From Benzinga
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
February 06, 2024
Tickers
ALNY
From Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
From Benzinga
From Benzinga
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
From Benzinga
Analyst Expectations for Alnylam Pharmaceuticals's Future
December 08, 2023
Tickers
ALNY
From Benzinga
Why Newly Listed Korro Bio Shares Are Gaining Today
December 04, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 11, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
October 11, 2023
From Benzinga
From Benzinga
2 Growth Stocks That Could Rocket Higher Before the End of 2023
October 08, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 05, 2023
From Benzinga
Analyst Expectations for Alnylam Pharmaceuticals's Future
September 29, 2023
Tickers
ALNY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
From Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
From Benzinga
Quant Ratings Updated on 98 Stocks
September 19, 2023
From InvestorPlace
Potential Label Restrictions Loom For Alnylam's Patisiran Despite Approval Prospects
September 14, 2023
Tickers
ALNY
From Benzinga
Despite FDA Doubts, Adcomm Backs Alnylam's Gene Silencing Therapy For Expanded Use Into Rare Heart Disease
September 14, 2023
From Benzinga
Nasdaq, S&P 500 Futures In Green As Traders Look Past Inflation Data; Analyst Singles Out Key Catalyst That Can Keep Year's Rally Going
September 14, 2023
From Benzinga
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.